Agilent announces new novocyte flow cytometer system software for 21 cfr part 11 compliance

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) today announced the release of new novoexpress software that introduces integrated compliance tools for novocyte flow cytometer systems. the compliance-enabling features enable users to meet regulatory requirements defined in fda 21 cfr part 11 and annex 11. there is immense pressure on pharmaceutical and biopharmaceutical manufacturers to demonstrate compliance with regulatory requirements such as 21 cfr part 11.
A Ratings Summary
A Quant Ranking